Date published: 2026-1-11

1-800-457-3801

SCBT Portrait Logo
Seach Input

Capsazepine (CAS 138977-28-3)

5.0(1)
Write a reviewAsk a question

See product citations (11)

Alternate Names:
N-[2-(4-Chlorophenyl)ethyl]-1,3,4,5-tetrahydro-7,8-dihydroxy-2H-2-benzazepine-2-carbothioamide
Application:
Capsazepine is an antagonist of TRPV1 and activator of ENaC
CAS Number:
138977-28-3
Purity:
≥97%
Molecular Weight:
376.90
Molecular Formula:
C19H21ClN2O2S
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Capsazepine is a competitive antagonist of the VR1 (TRPV1, also transient receptor potential vanilloid type 1), antagonizing the effects produced by Capsaicin at this receptor (sc-3577). The VR1 (TRPV1 receptor) is a non-selective ligand-gated cation channel that responds to noxious heat, protons, and Capsaicin, producing nociception signals. Capsazepine also activates ENaCdelta (amiloride-sensitive epithelial Na+ channel). Capsazepine is shown to inhibit the development of mechanical hyperalgesia induced by intraplanar capsaicin injection. Capsazepine is described to block Resiniferatoxin (sc-24015)- and Capsaicin-induced contractions of guinea pig treacheal smooth muscle. Studies investigating the function of the VR1 (TRPV1 receptor) have employed Capsazepine as a tool for perturbing systemic neuronal response to Capsaicin.


Capsazepine (CAS 138977-28-3) References

  1. The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and neuropathic pain.  |  Walker, KM., et al. 2003. J Pharmacol Exp Ther. 304: 56-62. PMID: 12490575
  2. Capsazepine: a competitive antagonist of the sensory neurone excitant capsaicin.  |  Bevan, S., et al. 1992. Br J Pharmacol. 107: 544-52. PMID: 1422598
  3. Current perspectives on the therapeutic utility of VR1 antagonists.  |  Valenzano, KJ. and Sun, Q. 2004. Curr Med Chem. 11: 3185-202. PMID: 15579007
  4. Capsazepine, a novel capsaicin antagonist, selectively antagonises the effects of capsaicin in the mouse spinal cord in vitro.  |  Urban, L. and Dray, A. 1991. Neurosci Lett. 134: 9-11. PMID: 1726117
  5. Selective antagonism of capsaicin by capsazepine: evidence for a spinal receptor site in capsaicin-induced antinociception.  |  Dickenson, AH. and Dray, A. 1991. Br J Pharmacol. 104: 1045-9. PMID: 1810591
  6. Capsazepine inhibits JAK/STAT3 signaling, tumor growth, and cell survival in prostate cancer.  |  Lee, JH., et al. 2017. Oncotarget. 8: 17700-17711. PMID: 27458171
  7. A comparison of capsazepine and ruthenium red as capsaicin antagonists in the rat isolated urinary bladder and vas deferens.  |  Maggi, CA., et al. 1993. Br J Pharmacol. 108: 801-5. PMID: 7682139
  8. The discovery of capsazepine, the first competitive antagonist of the sensory neuron excitants capsaicin and resiniferatoxin.  |  Walpole, CS., et al. 1994. J Med Chem. 37: 1942-54. PMID: 8027976
  9. Inhibition by capsazepine of resiniferatoxin- and capsaicin-induced contractions of guinea pig trachea.  |  Ellis, JL. and Undem, BJ. 1994. J Pharmacol Exp Ther. 268: 85-9. PMID: 8301598
  10. Capsazepine, a vanilloid receptor antagonist, inhibits nicotinic acetylcholine receptors in rat trigeminal ganglia.  |  Liu, L. and Simon, SA. 1997. Neurosci Lett. 228: 29-32. PMID: 9197280
  11. Capsazepine block of voltage-activated calcium channels in adult rat dorsal root ganglion neurones in culture.  |  Docherty, RJ., et al. 1997. Br J Pharmacol. 121: 1461-7. PMID: 9257928
  12. Ruthenium red and capsazepine antinociceptive effect in formalin and capsaicin models of pain in mice.  |  Santos, AR. and Calixto, JB. 1997. Neurosci Lett. 235: 73-6. PMID: 9389599

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Capsazepine, 5 mg

sc-201098
5 mg
$148.00

Capsazepine, 25 mg

sc-201098A
25 mg
$459.00